Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancer

• 主要な著者: Li-Yu Yang (著者), Jian-Ri Li (著者), Chuan-Shu Chen (著者), Chen-Li Cheng (著者), Sheng-Chun Hung (著者), Kun-Yuan Chiu (著者), Cheng-Kuang Yang (著者), Chiann-Yi Hsu (著者), Shian-Shiang Wang (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Objectives: Immune checkpoint inhibitor (ICI) is an important treatment option for metastatic urothelial carcinoma (mUC) patients. A lot of clinical evidence proved the survival benefits of ICI, but cost-effectiveness of the treatment remains unclear. This study evaluates the cost-effectiveness of t...